Jacquelyn Verme
Pediatrics · Miami, FLNPI 1659777175
Payments from drug & device makers
Across 254 payments — averaging $23.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$1K
- Tandem Diabetes Care, Inc.$790
- Sanofi-aventis U.S. LLC$594
- Abbott$425
- Sequel Med Tech, LLC$362
- AbbVie$315
- plus $2K from 29 others
Across 2 payments — averaging $59.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dexcom, Inc.$119
What the payments were for
- Food & beverage$5,90398%
- Gifts$1192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 49 | $1,060 |
| Tandem Diabetes Care, Inc. | 20 | $790 |
| Sanofi-aventis U.S. LLC | 21 | $594 |
| Abbott | 18 | $425 |
| Sequel Med Tech, LLC | 8 | $362 |
| AbbVie | 17 | $315 |
| Xeris Pharmaceuticals, Inc. | 14 | $298 |
| Novo Nordisk | 12 | $229 |
| Dexcom, Inc. | 20 | $223 |
| BETA Bionics, Inc. | 6 | $200 |
| Mannkind Corporation | 4 | $153 |
| Ascendis Pharma Endocrinology Inc | 5 | $125 |
| Lilly USA, LLC | 6 | $125 |
| AstraZeneca | 5 | $119 |
| Lifescan, Inc. | 6 | $116 |
| Amneal Pharmaceuticals LLC | 7 | $115 |
| Kyowa Kirin, Inc. | 4 | $93 |
| Zealand Pharma US, Inc. | 4 | $73 |
| Biomarin Pharmaceutical Inc. | 3 | $69 |
| Medtronic | 4 | $63 |
| Tolmar Pharmaceuticals, Inc. | 3 | $63 |
| Ultragenyx Pharmaceutical Inc. | 2 | $53 |
| Embecta Corp. | 2 | $42 |
| Soleno Therapeutics, Inc. | 1 | $41 |
| Rhythm Pharmaceuticals, Inc. | 2 | $39 |
| Amphastar Pharmaceuticals, Inc. | 2 | $38 |
| BD | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Tolmar, Inc. | 1 | $23 |
| EUSA Pharma (US) LLC | 1 | $23 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Endo USA, Inc. | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,022 in reported general payments places this provider in the 95th percentile of 3,964 pediatrics providers in Florida.
Other pediatrics in Miami
- Lilia Roque-GuerreroMiami$39.1M
- Nora DanielMiami$3.4M
- Giselle DeirosMiami$1.1M
- Pedro ReimonMiami$446K
- Georges SalibaMiami$428K
- Pedro Sanchez-DiazMiami$422K
- Isaac LuzardoMiami$177K
- Hilda BritoMiami$156K
- Alberto CottonMiami$132K
- Ramiro Alvarez DiazMiami$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.